JOSIAH ALDRUP: Open Payments
NPI 1184165748 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,762 in 103 payments from 13 companies in 2025. Trend: 2023 $1,177 · 2024 $1,446 · 2025 $2,762
Food & beverage: $2,704Honoraria: $58
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $703 |
| ABBVIE INC. | 11 | $365 |
| Janssen Pharmaceuticals, Inc | 8 | $330 |
| Supernus Pharmaceuticals, Inc. | 14 | $291 |
| Otsuka America Pharmaceutical, Inc. | 14 | $287 |
| Neurocrine BioSciences, Inc. | 7 | $188 |
| Vanda Pharmaceuticals Inc. | 13 | $175 |
| Collegium Pharmaceutical, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
Products named: ARISTADA, VRAYLAR, INVEGA SUSTENNA, Qelbree, REXULTI, INGREZZA, FANAPT, Jornay PM.
Industry payments across AL — which companies pay providers there.
